btg-im.com Report : Visit Site

Technical data of the btg-im.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host btg-im.com. Currently, hosted in United States and its service provider is Tierpoint Pennsylvania Two LLC .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

cookies on the btg interventional medicine website we use cookies to ensure that we give you the best experience on your website. if you continue without changing your setting. we'll assume that you are happy to receive all cookies on the btg website. yes, continue browsing find out more btg | interventional medicine united states (change) us user account search menu home about us interventional oncology interventional pulmonology vascular interventional oncology back interventional oncology back about btg im who we are 6 things about btg our manifesto a message from louise makin resources meet the expert corporate and regional press releases events noteworthy news webinars a message from louise makin, btg ceo about us interventional oncology back interventional oncology back our products lc bead ® lc bead m1 ® lc bead lumi ™ bead block ™ therasphere ® galil ™ io loop™ resources lc bead ® on balancing act corporate and regional press releases events noteworthy news interventional oncology interventional oncology back interventional oncology back our products repneu ® resources corporate and regional press releases events interventional pulmonology interventional oncology back interventional oncology back our products ekos ™ btg crossing devices varithena ® resources ekos catheter treatment corporate and regional press releases events vascular what are you looking for? search the site current country selected: united states current language selected: english country selector a argentina australia austria azerbaijan b bahrain belarus belgium bosnia-herzegovinia brazil brunei darussalam bulgaria c canada chile china colombia costa rica croatia cyprus czech republic d denmark dominica e egypt estonia f finland france g germany greece guatemala h hong kong hungary i iceland india indonesia ireland israel italy j japan jordan k kazakhstan korea (republic of) kuwait l latvia lebanon lithuania luxembourg m macedonia malaysia malta mexico montenegro morocco n netherlands new zealand norway o oman p panama paraguay peru philippines poland portugal q qatar r romania russian federation s saudi arabia serbia singapore slovakia slovenia south africa spain sri lanka sweden switzerland t taiwan thailand turkey u ukraine united arab emirates united kingdom united states uruguay v venezuela vietnam select your preferred language english immuno-oncology... the next frontier in cancer care <span class="white-caption">this year, btg expanded its collaboration with the society of interventional oncology to award nine research grants with the aim of devoloping greater collaboration in this emerging field of cancer treatment.</span> <a class="blue-button-icon" href="about-us/press-releases/view?press=sio-and-btg-announce-recipients-of-immuno-oncology"><span>find out more</span></a> things you should know about btg interventional medicine interventional oncology our products are used in minimally invasive procedures to treat people with various types of cancer, arteriovenous malformation and to provide palliative intervention targeting diseased cells while decreasing the impact on healthy tissue. interventional pulmonology for 10 years, we have been focussed on developing minimally-invasive medical devices for pulmonary diseases such as emphysema. interventional vascular btg helps interventional vascular teams solve problems with patients’ blood transport systems through evidence-based innovations that treat smarter and achieve more. previous next therasphere therasphere ® therasphere ® yields tumor necrosis using radiation as the primary mechanism of action, with a microembolic effect. 1,6 find out more lcbead lc bead ® lc bead ® is a controlled embolization system intended for the purpose of embolizing the blood vessels of a variety of hypervascularized tumors and arteriovenous malformations. lc bead ® is a preformed, deformable microsphere consisting of a biocompatible, sulphonate-modified, n-fil hydrogel. find out more lcbeadm1 lc bead m1 ® your choice for a controlled distal embolization. distal embolization may result in: less opportunity for the development of collateral circulation 3 greater likelihood of tumor necrosis 3 proximal embolization may result in: abundant development of collateral circulation 3 restricted ability to re-treat the target lesion from the same artery 3 find out more lc bead lumi lc bead lumi ™ lc bead lumi ™ is the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations in the us. find out more bead block bead block ™ the unique structure of bead block™ - pva hydrogel crosslinked with acrylic polymer - ensures smooth delivery and targeted, effective embolization, while resisting attrition, fragmentation and aggregation. 12, 13 find out more galil galil ™ galil ™ , a leading provider of cryoablation products for the treatment of kidney and other cancers provides clinicians with a broad product portfolio, supported by robust clinical data, to treat a wide range of diseases. find out more 1 2 3 4 5 6 previous next interventional pulmonology interventional pulmonology the emerging area of interventional pulmonology is dedicated to improving the lung function, exercise capacity and quality of life for patients with degraded lung function, including emphysema. 5 find out more previous next varithena varithena ® varithena ® is the first and only fda-approved foam for gsv system incompetence. it treats a wide range of vein anatomies and diameters above and below the knee. 4,11 find out more ekos™ ekos ™ ekos ™ is setting the standard for pe treatment safety and efficacy, again. with the ekos ™ treatment’s successful very-low dose and short duration regimens in the optalyse pe trial and favorable long term data results point to a paradigm-changing approach for pe treatment. find out more 1 2 learn more about our products lc bead lumi ™ , the first radiopaque embolic bead find out more lc bead ® on balancing act view the video ekos ® catheter treatment of massive & sub-massive pulmonary emboli view the video events 02 jun cair - canadian association for interven... 10 jun wcio - world conference on interventiona... 24 jun 2018 apaito all events corporate and regional press releases 07 sep btg plc acquires novate medical ltd. 23 jul optalyse pe results published in jacc: c... 21 jun pert consortium and btg form strategic p... all press releases information noteworthy news 28 apr optalyse pe results presented at society... 25 aug health canada approves radiopaque bead f... 17 may healthcare player btg on lookout for acq... all news information imagine where we can go... about btg about btg about btg im visit btg corporate website contact btg legal legal legal notice disclaimer privacy policy & cookies consent settings useful links useful links accessibility linkedin twitter btg linkedin twitter indications varithena ® (polidocanol injectable foam) is a prescription medicine used to treat varicose veins caused by problems with the great saphenous vein (gsv) and other related veins in the leg's gsv system. varithena ® improves symptoms related to or caused by varicose veins, and the appearance of varicose veins. important safety information you should not be treated with varithena ® if you are allergic to polidocanol or have clots in your blood vessels. severe allergic reactions have been reported in people treated with liquid forms of polidocanol and some patients have died from these reactions. varithena ® is a foam made from polidocanol. a healthcare professional will observe you for signs of allergic reactions for at least 10 minutes after you are treated with varithena ® . tell your doctor about all of your medical conditions, including if you have arterial disease (a disease of the blood vessels) have reduced mobility have a history of blood clots in the veins or lungs have had major surgery in the past 3 months have recently had a

URL analysis for btg-im.com

https://www.btg-im.com/en-US/en-gt
https://www.btg-im.com/en-US/#tab-prev
https://www.btg-im.com/en-US/en-gr
https://www.btg-im.com/en-US/en-us/therasphere/about/therasphere/about-therasphere
https://www.btg-im.com/en-US/about-us
https://www.btg-im.com/en-US/en-gb
https://www.btg-im.com/en-US/en-sa
https://www.btg-im.com/en-US/en-py
https://www.btg-im.com/en-US/en-th
https://www.btg-im.com/en-US/bead-block
https://www.btg-im.com/en-US/interventional-vascular/events
https://www.btg-im.com/en-US/#page
https://www.btg-im.com/en-US/interventional-pulmonology/press-releases
https://www.btg-im.com/en-US/about-us/press-releases/view?press=pert-consortium-and-btg-form-strategic-partnership
https://www.btg-im.com/en-US/en-pt

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: BTG-IM.COM
Registry Domain ID: 1846322057_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2016-04-06T11:46:23Z
Creation Date: 2014-02-12T09:18:37Z
Registry Expiry Date: 2019-02-12T09:18:37Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS10.DNSMADEEASY.COM
Name Server: NS11.DNSMADEEASY.COM
Name Server: NS12.DNSMADEEASY.COM
Name Server: NS13.DNSMADEEASY.COM
Name Server: NS14.DNSMADEEASY.COM
Name Server: NS15.DNSMADEEASY.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-09-11T04:55:42Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR MarkMonitor Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =btg-im.com

  PORT 43

  TYPE domain

DOMAIN

  NAME btg-im.com

  CHANGED 2016-04-06

  CREATED 2014-02-12

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS10.DNSMADEEASY.COM 208.94.148.4

  NS11.DNSMADEEASY.COM 208.80.124.4

  NS12.DNSMADEEASY.COM 208.80.126.4

  NS13.DNSMADEEASY.COM 208.80.125.4

  NS14.DNSMADEEASY.COM 208.80.127.4

  NS15.DNSMADEEASY.COM 208.94.149.4

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .